Clinical trial
Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition: a Randomized, Double Blind, Placebo-controlled Study
NCT06886061 is registered in ClinicalTrials.gov with Shanghai EGT Synbio Group Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Continuous Intake of Ergothioneine-containing Supplements on Skin Condition: a Randomized, Double Blind, Placebo-controlled Study
- Lead sponsor
- Shanghai EGT Synbio Group Co., Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 9, 2024
- Completion date
- March 3, 2025
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin